With their publication in June 2022 (1), the 3rd iteration of the Group for Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) Treatment recommendations for Psoriatic Arthritis (PsA) may have set a record or sorts.
A new subspecialty may emerge. New drugs will be approved (but it will be difficult for patients to get coverage for them). And an American team will win the World Series. All these and more: here are predictions for 2017 and beyond from rheumatologists across the country and around the world.
The DRESS syndrome is a rare and sometimes catastrophic disorder resulting from specific drug exposures, including allopurinol, minocycline, INH, anticonvulsants or retroviral agents.
Highlights and take-home messages from the Cleveland Clinic Center for Continuing Education's Biologic Therapies Summit held this week (April 30 – May 2, 2015).